Navigation Links
Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
Date:5/31/2009

ORLANDO, Fla., May 31 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today that Phase III trial data showed the addition of Lilly's GEMZAR(R) (gemcitabine HCl for injection) to the current standard of care provided a statistically significant increase in progression-free survival at three years for women with locally advanced cervical cancer.

Cervical cancer is the world's second most commonly diagnosed women's cancer, and the second most common cause of cancer death in women.(1)

The current standard of care for women with locally advanced cervical cancer consists of the chemotherapy cisplatin and radiation (chemoradiation). This has been the recommended course of treatment since 1999.

Results from this global, multicenter, open-label, randomized Phase III trial were presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) during an ASCO-sponsored press conference on May 31 at 8:30 a.m. EDT, and as an oral presentation at the meeting at 10:30 a.m. EDT (ASCO Abstract #CRA5507).(2)

With 515 patients evaluated, the data showed a statistically significant (p=0.029) increase in progression-free survival at three years for patients treated with the gemcitabine chemoradiation combination versus those treated only with chemoradiation (74% vs. 65%, respectively). Patients on the gemcitabine arm experienced significantly more grade 3/4 toxicities. Additionally, two patients on the gemcitabine arm died due to causes possibly attributed to treatment-related toxicities. Most side effects were hematologic, including anemia (low red blood cell count), neutropenia (low white blood cell count) and thrombocytopenia (low blood platelet count).

"While there have been tremendous advances in cervical cancer prevention in the form of early screening and vaccination, oncologists have essentially been using the same treatment standard for the last
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 ... report "Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT ... - I-131, Alpha Emitters, Brachytherapy - Y-90), by ... 2020", published by MarketsandMarkets, this report studies the ... of 2015 to 2020. This market is expected ...
(Date:7/7/2015)... South Korea and FREMONT, Calif. ... of South Korea and Velos, Inc. ... use of Velos eResearch for cancer research nationally throughout ... other research partners. The recent agreement signing was accompanied by ... Seoul , South Korea.  National ...
(Date:7/7/2015)... Berger & Montague, P.C., a full-spectrum ... with one of the largest and most successful ... and Faruqi, LLP in settling three separate but ... LP, Cephalon, Inc., and Biogen, Inc., for a ... the agreements, AstraZeneca will pay the largest sum, ...
Breaking Medicine Technology:Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3
... 2011 Novus Scientific today announced the peer-reviewed publication of unique pre-clinical ... Mesh – the world,s first long-term absorbable surgical mesh. ... - The World Journal of Hernia and Abdominal Wall ... TIGR ® Matrix versus a permanent mesh ...
... Calif., Oct. 6, 2011 Inogen has expanded its home ... of Florida. An innovator in oxygen therapy products and services, ... therapy users throughout the country and is now able to ... The State of Florida has the largest percentage ...
Cached Medicine Technology:Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh 2Inogen's Home Oxygen Therapy Service Expands to Florida 2
(Date:7/7/2015)... ... July 07, 2015 , ... Quadrino Law Group is pleased ... 304, Melville, New York 11747. The new facility is a state of the ... lines. , Richard Quadrino, the firm's CEO and founder, said, "We are pleased to ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team ... green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only ... , On this initiative Cotton explained, “We send anything between 300 and 600 pieces of ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to announce ... an anesthesiologist and pain management specialist, will be evaluating and treating patients with orthopedic ... , After receiving his Bachelor of Science in Biology from the University of the ...
(Date:7/7/2015)... ... July 07, 2015 , ... FSAstore.com today announced the ... HSA holders. HSAstore.com makes it simple to use, spend and manage HSA funds with ... their accounts. , According to a report by Devenir , approximately 13.8 ...
(Date:7/7/2015)... NH (PRWEB) , ... July ... ... integrated, full-service public relations, marketing, and creative design firm, today announced that ... regional public relations and social media campaign, content strategy, and marketing launch ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2
... , SAN ANTONIO, Aug. 24 Fall 2009 ... family schedules, which can have a devastating impact on family pets that ... PurinaCare(R) Pet Health Insurance ( www.purinacare.com ), which is committed to help ... all pet owners to be aware of the signs of post-summer ...
... Two professors at Baylor University,s Hankamer School of Business ... book Health Care for Us All: Getting More for Our ... a government entitlement program or threaten in any way the ... coverage. , , First and foremost, say ...
... NANJING, China, Aug. 24 /PRNewswire-Asia/ -- Simcere ... "Company"), a leading manufacturer and supplier,of branded generic and ... Sun Yat-Sen University Cancer Center. , ... is one of,China,s renowned cancer research institutions, prominent in ...
... , , EUGENE, Ore., Aug. ... techaidinstitute.com , is launching a national campaign to ... to protect themselves from germs that include the 2009 flu ... With alarming reports of this virus already hitting the United ...
... , , , SIGNAL ... medical technology systems integrator transforming critical care, announced that it ... of Defense for additional enhancements of the company,s MedEx 1000(TM) ... "While these funds were included in an earlier announcement, we ...
... Creativity and vision ... LASIK eye surgery in Arizona is sponsoring a new contest that will award the most ... contest may help one lucky winner change the way they view the world. , ... (Vocus) August 24, 2009 -- What exactly would you ...
Cached Medicine News:Health News:Does Your Pet Have Post-Summer Separation Anxiety? 2Health News:Does Your Pet Have Post-Summer Separation Anxiety? 3Health News:Baylor University Economists Call for Different Tack on Health Care Insurance 2Health News:Simcere Announces Strategic Partnership with Sun Yat-Sen University Cancer Center 2Health News:Oregon Company Launches National Campaign to Help Protect People with Intellectual Disabilities from the Swine Flu 2Health News:Integrated Medical Systems Receives $1.1 Million From the U.S. Department of Defense for Critical Enhancements of the World's First 'Suitcase' Intensive Care Unit 2Health News:Integrated Medical Systems Receives $1.1 Million From the U.S. Department of Defense for Critical Enhancements of the World's First 'Suitcase' Intensive Care Unit 3Health News:LASIK Eye Surgery Practice in Phoenix Arizona Giving Away Free LASIK to Winner of New Video Contest 2Health News:LASIK Eye Surgery Practice in Phoenix Arizona Giving Away Free LASIK to Winner of New Video Contest 3
... vital sign monitor. , ,Adult, pediatric, and neonatal. ... in patient care., ,Standard Functions: ,ECG - Respiration ... Multi-gas Sensor (HAL, ENF, ISO, DES, SEV, N ... ECG - FiO 2 - 2-Invasive Pressures - ...
... CS makes the outstanding ... CS even more flexible. ... Technologies, the Wireless Propaq ... ethernet Local Area Networks ...
... Monitoring Station provides alarm and vital ... patients from a single computer workstation. ... and click actions with a computer ... initiate or change monitoring functions from ...
The Micropaq includes many of the features of the Propaq portable monitors such as waveform display, multi-parameters, and alarm capabilities in a small, rugged, and lightweight patient-wearable devi...
Medicine Products: